Ignite Creation Date:
2025-12-24 @ 1:33 PM
Ignite Modification Date:
2026-04-10 @ 12:00 AM
Study NCT ID:
NCT00102895
Status:
TERMINATED
Last Update Posted:
2010-08-27
First Post:
2005-02-03
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Research Study of CP-724,714 in Patients With HER2 Overexpressing Metastatic Breast Cancer
Sponsor:
Pfizer
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
A4031003
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Director, Clinical Trial Disclosure Group
Old Organization:
Pfizer, Inc.